Our industry experts understand the challenges and rigorous demands of pharmaceutical name development. Since 2008, Addison Whitney has developed and/or tested more than 150 brand names that have been approved by global health authorities.
We make it our mission to stay up to date on the latest regulations and approval requirements. It's because of this dedication that we're able to proudly say we exceed industry standards when it comes to name approval rates.
We fully understand and effectively address the complex issues healthcare and pharmaceutical brands face – issues such as patient safety concerns, FDA, EMA and Health Canada regulations and global trademark development. Our expertise spans domestic and international markets, pharmaceutical brand naming and USAN and INN naming.
We deliver healthcare and pharmaceutical brands that integrate creativity, business strategy, trademark viability and regulatory compliance. We take pride in our reputation for consistently helping clients achieve approval for names that meet all of their brand objectives.
Our verbal capabilities include:
- Brand Name Development (Corporate/Product/Service)
- INN/USAN Development
- Clinical Trial Naming
- Global Trademark Prescreening
- Global Linguistic Evaluation